Mobile Site ›

Laboratory Testing for Hepatitis B



Chronic Hepatitis B Therapeutic Options

Slide 14

June 2008

In the United States, currently the therapeutic options that are FDA-approved are shown on this slide. There are two forms of interferon preparations for treating chronic Hepatitis B, and there are three nucleoside analogs, (top 3). The other two agents are actually approved by the FDA for treating HIV infection, but they have been used by hepatologists for treating drug resistant chronic Hepatitis B.

Finally the last class of FDA-approved anti-Hepatitis B viral agent is Adefovir which is a nucleotide analog.

Chronic Therapeutic Options

 


Jump to section:


Key